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Abstract
Introduction—Most successfully resuscitated cardiac arrest patients do not survive to hospital 
discharge. Many have withdrawal of life sustaining therapy (WLST) as a result of the perception 
of poor neurologic prognosis. The characteristics of these patients and differences in their post-
arrest care are largely unknown.
Methods—Utilizing the Penn Alliance for Therapeutic Hypothermia Registry, we identified a 
cohort of 1311 post-arrest patients from 26 hospitals from 2010 to 2014 who remained comatose 
after return of spontaneous circulation. We stratified patients by whether they had WLST post-
arrest and analyzed demographic, arrest, and post-arrest variables.
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Results—In our cohort, 565 (43%) patients had WLST. In multivariate regression, patients who 
had WLST were less likely to go to the cardiac catheterization lab (OR 0.40; 95% CI: 0.26–0.62) 
and had shorter hospital stays (OR 0.93; 95% CI: 0.91–0.95). When multivariate regression was 
limited to patient demographics and arrest characteristics, patients with WLST were older (OR 
1.18; 95% CI: 1.07–1.31 by decade), had a longer arrest duration (OR 1.14; 95% CI: 1.05–1.25 
per 10 min), more likely to be female (OR: 1.41; 95% CI: 1.01–1.96), and less likely to have a 
witnessed arrest (OR 0.65; 95% CI: 0.42–0.98).
Conclusion—Patients with WLST differ in terms of demographic, arrest, and post-arrest 
characteristics and treatments from those who did not have WLST. Failure to account for this 
variability could affect both clinical practice and the interpretation of research.
Keywords
Cardiopulmonary resuscitation; Heart arrest; Brain; Epidemiology; Prognosis
Introduction
Individuals who suffer cardiac arrest experience high rates of morbidity and mortality. Even 
when patients survive the initial arrest event, prognosis can be poor.1,2 Until the last few 
decades, it was assumed that the chances of regaining meaningful functional neurologic 
recovery in survivors who remained comatose post-arrest were low. However, with the use of 
more aggressive bundles of care focusing on targeted temperature management (TTM) and 
hemodynamic optimization, outcomes are improving, and more patients are discharged from 
the hospital with meaningful neurologic recovery.3–5
Despite these advances, most post-cardiac arrest patients suffer some degree of anoxic brain 
injury.6 This brain injury, or at least the expectation of it, is a common cause of death for 
post-arrest patients.7,8 The majority of successfully resuscitated post-arrest patients who 
remain comatose die after withdrawal of life-sustaining therapies (WLST) based on a 
presumed poor neurologic outcome.7,9–11 This is appropriate for patients with non-
recoverable neurologic injuries, but post-arrest prognosis is difficult and it often takes many 
days post-arrest to determine outcomes.6,8 Indeed, remaining comatose post-arrest may lead 
patients to have WLST earlier than recommended for an “adequate” neuroprognostic 
decision to be made.9,10
Although guidelines address the need for neuroprognostication in WLST decision-making, 
the specific factors potentially influencing the decision to pursue WLST remain 
incompletely explored. To address this gap in knowledge, we sought to characterize the 
demographic, arrest, and post-arrest factors associated with WLST in post-arrest patients.
Methods
This is a retrospective cohort study utilizing data from the Penn Alliance for Therapeutic 
Hypothermia (PATH) Registry. The PATH registry is a national, online repository for patient 
data from multiple centers utilizing TTM in the management of post-cardiac arrest patients. 
This was a multi-center study evaluating patient data from 27 institutions and was approved 
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by the University of Pennsylvania Institutional Review Board with a waiver of informed 
consent.
We identified adult comatose post-arrest patients between 2010–2014 from the PATH 
registry with information on do not resuscitate (DNR) orders and WLST. Patients were 
excluded if they were not successfully resuscitated post-cardiac arrest, if they were younger 
than 18 years of age, and if they had missing information on DNR status or outcome at 
hospital discharge. Patient demographic data including age, race and sex were compiled. The 
following patient comorbidities were abstracted: acute stroke or transient ischemic attack, 
chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), dementia, 
diabetes mellitus (DM), end stage renal disease (ESRD), hypertension, metastatic or hema-
tologic cancer, peripheral vascular disease (PVD), HIV/AIDS, and congestive heart failure 
(CHF). Finally, arrest variables (location of arrest, suspected etiology, initial pulseless 
rhythm, and duration of arrest), and post-arrest variables (whether the patient received TTM, 
had documented neurology or cardiology consultations, went to the cardiac catheterization 
laboratory, went to the electrophys-iology laboratory, had electroencephalography (EEG) 
performed, had a computerized tomography (CT) scan of the head or brain Magnetic 
Resonance Imaging (MRI), had echocardiography performed, and the length of hospital 
stay) were collected for each patient. The primary outcome, WLST, was documented in the 
chart by the attending critical care physician and was defined not simply as change in code 
status, but as the decision to actively withdraw supportive therapies and provide comfort 
measures only.
Differences in categorical variables by primary outcome (WLST versus no WLST) were 
analyzed using Chi-square tests. Continuous variables were checked for normality using the 
skewedness and kurtosis test for normality and then analyzed using a Mann–Whitney U test 
to compare the differences in medians by group. To analyze the relationship between 
patient- and arrest-level variables and WLST, a multivariate logistic regression model was fit 
using demographic and arrest factors in order to assess how these variables contribute to 
WLST. Covariates were included in this model if they had a p-value ≤ 0.2512,13 and removed 
from the model using backward elimination using Stata 12.1 (College Station, TX). Potential 
effect modifiers were examined and model fit was examined both with and without the 
interaction term(s). In order to evaluate the relationship between post-arrest care modalities 
and WLST while controlling for patient-level variability, a series of logistic regressions were 
fit controlling for the relevant demographic and arrest characteristics, as determined by the 
previous analysis. Tests for trend across ordered groups was performed to assess changes in 
rates of WLST by year and changes in percentage of WLST performed prior to 72 h post-
arrest by year. As this was a multi-center study, post-estimation likelihood ratio tests were 
performed to evaluate the extent of clustering by site.
Results
Of 1311 patients meeting inclusion criteria, 565 (43%) patients had WLST. These patients 
differed in demographic, arrest, and post-arrest characteristics and treatments (Table 1). 
Patients with WLST were more likely to be older, female, have an unwitnessed arrest, have 
an initial non-shockable rhythm, and have longer duration of arrest. They were more likely 
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to have an EEG performed and to have a shorter hospital length of stay. They were less 
likely to have TTM performed, a consultation from the cardiology service, go to the cardiac 
catheterization lab, have an MRI of the brain, or have echocardiography performed. In terms 
of comorbidities, patients with WLST were statistically more likely to have COPD, CAD, 
DM, hypertension, PVD, metastatic cancer, and CHF, but statistically less likely to have a 
history of acute stroke or transient ischemia attack. The median length of stay was 
significantly longer in the patients without WLST (WLST: 2 [IQR: 1, 5] days; no-WLST: 10 
[IQR: 2, 17]; Fig. 1).
When multivariate regression was limited to patient demographics and arrest characteristics 
(age, race, sex, whether the arrest was witnessed, duration of arrest, an interaction between 
etiology of arrest and initial rhythm), patients with WLST were older (OR 1.18; 95% CI: 
1.07–1.31 by decade), had a longer duration of arrest (OR 1.14; 95% CI: 1.05–1.25 for each 
additional 10 min of pulselessness), were more likely to be female (OR: 1.41; 95% CI: 1.01–
1.96), and were less likely to have a witnessed arrest (OR 0.65; 95% CI: 0.42–0.98). In 
multivariate regression analysis controlling for the same demographic and arrest 
characteristics as well as the year of arrest, patients who had WLST were less likely to go to 
the cardiac catheterization lab (OR 0.40; 95% CI: 0.26–0.62), and had shorter hospital stays 
(OR 0.93; 95% CI: 0.91–0.95 by day).
Information on timing of WLST was available in 553/565 (97.9%) patients with WLST. 
294/553 (53.2%) of patients who had WLST had it occur in the first 48 h post-arrest (“early 
WLST”; Table 2). Patients with early WLST were more likely to be older, white, female, 
and have an initial non-shockable rhythm, a non-cardiac etiology of arrest, an in-hospital 
cardiac arrest, and a longer duration of arrest. They were less likely to have an 
electroencephalogram (EEG) performed, receive targeted temperature management (TTM) 
or a consultation from the cardiology or neurology service, go to the cardiac catheterization 
lab, have a head CT, or have echocardiogra-phy performed. In terms of comorbidities, 
patients with early WLST only differed from those without in that they were statistically less 
likely to have a history of acute stroke or transient ischemia attack (TIA). The median length 
of stay was significantly shorter in the patients with early WLST (1 [IQR: 0, 1] day vs. 8 
[IQR: 3, 16] days).
When multivariate regression was limited to patient demographics and arrest characteristics 
(age, race, sex, whether the arrest was witnessed, duration of arrest, etiology of arrest, and 
initial rhythm), patients with early WLST were older (OR 1.34; 95% CI: 1.19–1.50 by 
decade), had a longer duration of arrest (OR 1.12; 95% CI: 1.03–1.21 for each additional 10 
min of pulselessness), were more likely to be female (OR: 1.54; 95% CI: 1.08–2.21), were 
less likely to have a shockable initial rhythm (OR: 0.43; 95% CI: 0.28–0.66) and were less 
likely to be African–American (OR 0.56; 95% CI: 0.36–0.87). In multivariate regression 
analysis controlling for the same demographic and arrest characteristics as well as the year 
of arrest and for clustering by hospital, patients who had early WLST were less likely to be 
treated with targeted temperature management (OR: 0.37; 95% CI: 0.21–0.63) to have a 
neurology consultation (OR: 0.31; 95% CI: 0.20–0.47), to have a cardiology consultation 
(OR: 0.35; 95% CI: 0.20–0.62), go to the cardiac catheterization lab (OR 0.29; 95% CI: 
0.17–0.50), have a head CT (OR: 0.27; 95% CI: 0.15–0.50), have echocardiography 
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performed (OR: 0.20; 95% CI: 0.13–0.30), and have EEG performed (OR: 0.24; 95% CI: 
0.13–0.45). We compared demographic and arrest characteristics in patients by timing of 
WLST/death in non-survivors (first 2 days, days 3–7, and after day7) and in survivors and 
found no clear systematic differences or trends (Supplemental Table S1 in the online version 
at DOI:http://dx.doi.org/10.1016/j.resuscitation.2016.10.021). We also limited the 
population to OHCAs and found little change in associations in most univariate and 
multivariate analyses (Supplemental Tables S2 and S3 in the online version at DOI:http://
dx.doi.org/10.1016/j.resuscitation. 2016.10.021). Of note, the associations between race and 
sex in the early WLST group were no longer significant, and OHCA patients with early 
WLST were found to receive significantly fewer brain MRIs.
There was a significant trend toward increased rates of WLST by year (Fig. 2). However, 
there was no significant difference in the rates of WLST prior to 72 h post-arrest by year. 
Our statistical evaluation of clustering by site did not yield evidence of any changes in 
association.
Discussion
Our findings show that, in adjusted analysis, patients with withdrawal of life-sustaining 
therapies were older and more likely to be female, have a longer duration of arrest, and to 
have had an unwitnessed arrest. They were also more likely to have certain comorbidities: 
COPD, CAD, DM, hypertension, PVD, metastatic cancer, and CHF. This analysis clearly 
outlines that patients with WLST have different characteristics than those that do not. 
Additionally, in patients with WLST, those with “early WLST” were older and more likely 
to be female, have a longer duration of arrest, have an initial non-shockable rhythm, and less 
likely to be African–American than those with later WLST. They were also less likely to 
have experienced an acute stroke or TIA. Whether this is the effect of provider bias or the 
result of pathophysiologic difference cannot be inferred from this study; however, our 
analysis accounted for physiologic difference between cohorts.
Our results are similar to a recent publication looking at early WLST versus late WLST 
post-arrest. This study found that 52% of comatose post-arrest patients had WLST and that 
the decision to withdraw these therapies was influenced by age, race, preexisting 
comorbidities, multi-organ failure, and a poor initial neurologic exam.14 Although we did 
not investigate the effect of multi-organ failure or the initial neurologic exam, we did find 
similar results for age, with older patients more likely to have WLST and more likely to 
have early WLST. We did not find a statistically signifi-cant relationship between race and 
WLST, but we did find that a larger proportion of patients who had WLST versus no WLST 
were white (72.7% vs. 67.0%), a trend that was reversed in African Amer-ican patients 
(21.9% vs. 25.0%) (p = 0.08). Although not statistically significant, this trend does allude to 
a possible racial disparity in the utilization of WLST. Additionally, African Americans were 
significantly less likely to have WLST in the first 48 h. In contrast to the above work, which 
found no difference between patients with certain cormorbidities,14 we found that patients 
with certain comorbidities (specifically, those with COPD, CAD, DM, hypertension, PVD, 
metastatic cancer, and CHF) were more likely to have WLST, a difference that could be 
explained by comparative sample sizes.
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Looking at the utilization of withdrawal of life-sustaining therapy is of vital importance in 
post-arrest care—it is not only prevalent,11 but also variable. A study done by Sandroni et al. 
that explored the application of neuroprognostic tools in patients treated with therapeutic 
hypothermia found that the quality of evidence supporting the use of these tools ranged from 
“Very Low” to “Moderate”, and that none were good predictors of neurologic recovery. The 
authors concluded that in the first 7 days post-arrest, some of these tools, such as a 
bilaterally absent N20 somatosensory evoked potential (SSEP) wave or a nonreactive EEG 
after rewarming, were useful for predicting poor neurologic outcome, but that these tools 
were accompanied by a high risk of bias.3 Unfortunately, many patients have WLST prior to 
7 days post-arrest – median time to WLST was only 2 (IQR: 1, 5) days post-arrest in this 
study and was previously documented as 3 (IQR:1–5) days in another13 – which results in 
decisions prior to the application of these prognostic tools and the possibility of death in a 
patient who may have had a different outcome if given further time to awaken or undergo 
further neuroprognostic testing.
Despite the imprecision of post-arrest neuroprognostic tools, many patients who survive 
initial resuscitation die as a result of WLST due to suspected neurologic causes. One study, 
which looked at the cause of death in ICU-admitted post-arrest patients who died before 
hospital discharge, found that suspected neurologic injury was the cause of death in 58/126 
non-survivors (46%), which differed based on location of arrest: 68% of patients with out of 
hospital arrests had suspected neurologic injury as the cause of death compared to 23% of 
patients with in-hospital arrests.7 A similar study looked at 58 patients and found that 40 
patients died as a result of withdrawal of life-sustaining therapies, 8 died as a result of brain/
cardiac death, and 10 survived, which means that 83% of non-survivors had WLST—
showing how common this practice is. Another study of 55 TTM-treated patients with 
arrests between 2005–2009 found that 57% patients had a negative neurologic prognosis 
within 15 h after being rewarmed; 25% of these had WLST prior to 72 h post-arrest. Most 
astonishingly, 21% of the patients given a poor prognosis had a good neurologic outcome at 
hospital discharge9; showing how important understanding the mechanisms behind WLST is 
both to patients and to clinical research.
As medical resources are finite, it is important to recognize that some post-arrest patients 
will not have a reasonable hope of recovery and may not benefit from the continued use of 
considerable resources that could be allocated elsewhere. However, there is a lack of 
standardized protocol for determining these patients and deciding to withdraw life sustaining 
therapy within and between institutions as well as a lack of consensus for what this protocol 
should entail. In a large randomized controlled trial (RCT) in Europe examining two 
different target temperatures for post-arrest targeted temperature management,3 Nielsen et 
al. actively worked to reduce the potential bias by using a protocol across the entire RCT. 
This protocol required that all patients be actively treated until 72 h after the intervention 
period (108 h post-arrest) and then specified when neurological evaluation would be done on 
comatose patients, protocolized what the examination would entail, and documented the 
rationale for all WLST,11 showing that it is possible to adopt a well-defined standard 
protocol for WLST. Additionally, no patient could have therapy withdrawn for neurologic 
reasons prior to 72 h post-arrest, except in cases of cerebral herniation or early myoclonus 
status with a negative SSEP.3 This protocol differs vastly from what we found in this study
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—contrary to waiting 4.5 days prior to beginning to assess patients for WLST as stated in 
the protocol, patients had life-sustaining therapies withdrawn a median of 2 days post-arrest, 
which is consistent with findings in in-hospital patients.15 This disconnect and the variability 
in prac-tice highlights the importance of accounting for WLST and delving further into the 
mechanisms behind current practices.
However, a recent multi-center randomized controlled trial aimed at improving adherence to 
neuroprognostication protocols showed that a quality improvement intervention increased 
rates of appropriate neuroprognostication. Although this trial did not show significant 
improvement in survival, it does provide support for the feasibility of successful 
implementation of a standardized protocol.16
Without standardization, the results of cardiac arrest research, especially those with 
neurologic status as a primary or secondary outcome, could be severely biased. We have 
shown that there is variability of care around WLST, which can lead to self-fulfilling 
prophecies in which life-sustaining therapies are withdrawn in patients with the potential to 
recover neurologically. This can lead to an overestimation of the ability of a test to predict 
bad outcome and affect the modalities used to neuroprognosticate. Neuroprog-nostic tests 
are also usually ordered for a specific reason, which could lead to spectrum bias, causing an 
over- or under-estimation of the utility of the prognostic tools being applied when making 
the decision to WLST. A recent study of 16,875 OHCAs estimated that early withdrawal of 
care due to expected poor neurologic prognosis was associated with an annual excess 
mortality of 2300 patients in the US, 64% of whom may have had a favorable functional 
outcome (as measured by a modified Rankin score 3 at hospital discharge).17 Not accounting 
for the effects of WLST ≤ variability is potentially harmful both clinically and in 
resuscitation research, especially given our finding that there is a trend over time toward 
increased WLST.
There were multiple limitations in our study; most notably, this investigation was an analysis 
of retrospectively collected data. Relying on medical records and documentation with the 
purpose of patient care as opposed to research inevitably leads to miss ing data and the 
potential for misclassification. Additionally, the use of registry data limits data to only pre-
specified and defined data points and can lead to a loss of nuance by limiting response 
choices. As there is currently no standard practice for WLST and this is a multi-center study, 
protocols, practice, and patient composition could vary widely by site and add spurious 
heterogeneity, although we did not find significant evidence of this. However, use of a 
registry allowed for this evaluation of over 1300 patients at 26 American institutions, the 
largest study of WLST in this population. Finally, without thorough documentation of the 
processes that went into the decision to withdraw life-sustaining therapies, particularly 
because our data set does not delineate which patients had WLST due to neurologic poor 
prognosis versus medical futility, we have no way to determine which factors were deemed 
important by the healthcare proxy in ultimately deciding whether to withdrawal life-
sustaining therapies in a particular patient.
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Conclusions
In conclusion, comatose post-arrest patients who had WLST in the hospital were older, were 
more likely to have a longer arrest downtime, be female, have an unwitnessed arrest, and 
have COPD, CAD, DM, hypertension, PVD, metastatic cancer, and CHF. They are more 
likely to have post-arrest neurology and cardiology consults, less likely to go to the 
electrophysiology lab, and have a shorter hospital stay. Further investigation is necessary to 
understand the intricacies that contribute to decisions surrounding WLST as well as the 
timing of decision in post-arrest patients who remain comatose despite post-cardiac arrest 
care.
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Fig. 1. 
Post-arrest hospital length of stay by withdrawal of life-sustaining therapies (WLST).
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Fig. 2. 
Percentage of patients with withdrawal of life-sustaining therapies by year.
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Table 1
Comparison of patients with WLST and those who did not have WLST.
WLST (n = 565) No WLST (n = 746) p-value
Age (median [IQR] years) 67 (56, 78) 62 (51, 72) <0.001
Race
 White 72.7% 67.0%
 Black 21.9% 25.0%   0.082
 Other 5.4% 8.0%
Male 53.7% 63.1%   0.001
Comorbidities
Acute stroke/transient ischemic attack 2.1% 4.3%   0.033
Chronic pulmonary obstructive disorder 11.0% 5.6% <0.001
Coronary artery disease 18.8% 14.2%   0.026
Dementia 3.0% 1.8%   0.341
Diabetes mellitus 23.1% 16.2%   0.002
Hypertension 33.7% 27.2%   0.012
Cancer 6.6% 3.9%   0.030
Peripheral vascular disease 6.0% 2.9%   0.006
End stage renal disease 5.7% 5.2%   0.682
HIV/AIDS 0.2% 0.0%   0.265
Congestive heart failure 21.1% 12.3% <0.001
Witnessed 76.4% 83.8%   0.002
Cardiac etiology of arrest 61.8% 72.3% <0.001
Out-of-hospital arrest 58.6% 62.7%   0.132
Initial rhythm
 VF/VT 24.8% 43.6%
 Asystole 30.3% 20.3% <0.001
 PEA 44.9% 36.0%
Duration of arrest (median [IQR] minutes) 20 (9, 34) 13 (8, 25) <0.001
Targeted temperature management 54.3% 65.2% <0.001
Neurology consultation 64.2% 60.2%   0.328
Cardiology consultation 70.9% 81.0%   0.005
Cardiac catheterization lab 19.5% 43.9% <0.001
Electrophysiology lab 1.5% 8.6% <0.001
Electroencephalography 52.2% 47.8%   0.301
Head CT scan 58.7% 62.5%   0.383
Brain MRI scan 4.6% 9.5%   0.037
Echocardiography performed 60.2% 72.2%   0.003
Hospital length of stay (median [IQR] days) 2 (1, 5) 10 (2, 17) <0.001
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Table 2
Comparison of patients with WLST in the first 48 h post-arrest and those without WLST/WLST after 48 h 
post-arrest.
WLST in 1st 48 h (n = 294) No WLST or WLST after 48 h (n = 1005) p-Value
Age (median [IQR] years) 71 (59, 80) 62 (52, 73) <0.001
Race
 White 75.9% 67.5%
 Black 18.9% 25.2%   0.040
 Other 5.2% 7.2%
Male 50.9% 61.2%   0.001
Comorbidities
Acute stroke/transient ischemic attack 0.7% 4.2%   0.004
Chronic pulmonary obstructive disorder 7.8% 8.1%   0.902
Coronary artery disease 14.6% 16.7%   0.395
Dementia 2.4% 1.8%   0.474
Diabetes mellitus 18.7% 19.2%   0.843
Hypertension 28.2% 30.2%   0.519
Cancer 7.1% 4.5%   0.071
Peripheral vascular disease 5.1% 4.1%   0.449
End stage renal disease 3.4% 6.1%   0.079
HIV/AIDS 0.3% 0.0%   0.235
Congestive heart failure 17.7% 15.8%   0.438
Witnessed 81.2% 80.5%   0.804
Cardiac etiology of arrest 61.1% 67.8%   0.040
Out-of-hospital arrest 48.0% 64.2% <0.001
Initial rhythm
 VF/VT 18.8% 40.2%
 Asystole 32.8% 22.3% <0.001
 PEA 48.5% 37.5%
Duration of arrest (median [IQR] minutes) 19 (8, 34) 15 (8, 29)   0.048
Targeted temperature management 34.4% 68.0% <0.001
Neurology consultation 41.3% 67.9% <0.001
Cardiology consultation 55.8% 80.9% <0.001
Cardiac catheterization lab 14.0% 38.1% <0.001
Electrophysiology lab 0.4% 6.9% <0.001
Electroencephalography 25.7% 56.1% <0.001
Head CT scan 37.1% 66.4% <0.001
Brain MRI scan 3.2% 8.0%   0.104
Echocardiography performed 38.0% 73.5% <0.001
Hospital length of stay (median [IQR] days) 1 (0, 1) 8 (3, 16) <0.001
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